YARROW BIOSCIENCE, INC. Increase (Decrease) in Prepaid Expense and Other Assets
YARROW BIOSCIENCE, INC. (YARW) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$462.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$260.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$202.00K, a 126.30% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was -$1.07M, a 137.95% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-03-31 was $768.00K, a 40.65% decline year-over-year.
- YARROW BIOSCIENCE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$405.00K.
- YARROW BIOSCIENCE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$11.21M.
- YARROW BIOSCIENCE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2021 was -$7.71M, a 144.98% decline from fiscal 2020.
- YARROW BIOSCIENCE, INC. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $17.14M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$260.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | -$462.00K 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | -$202.00K S-4/A · filed 2026-06-03 | |||||
| 2025-12-31 | -$4.21M S-4/A · filed 2026-06-03 | |||||
| 2025-06-30 | -$1.07M derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | -$306.00K 10-Q · filed 2026-08-13 | -$994.00K derived: sum of 3 quarters · filed 2026-08-13 | -$3.53M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $768.00K S-4/A · filed 2026-06-03 | $80.00K derived: sum of 2 quarters · filed 2026-06-03 | -$2.46M derived: sum of 3 quarters · filed 2026-06-03 | $373.00K derived: sum of 4 quarters · filed 2026-06-03 | ||
| 2024-12-31 | -$688.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | -$3.23M derived: sum of 2 quarters · filed 2026-06-03 | -$395.00K derived: sum of 3 quarters · filed 2026-06-03 | $899.00K S-4/A · filed 2026-06-03 | ||
| 2024-09-30 | -$2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $293.00K derived: sum of 2 quarters · filed 2025-08-14 | $1.59M 10-Q · filed 2024-11-07 | $2.20M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-06-30 | $2.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $4.12M 10-Q · filed 2025-08-14 | $4.74M derived: sum of 3 quarters · filed 2025-08-14 | $4.24M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $1.29M 10-Q · filed 2025-05-08 | $1.91M derived: sum of 2 quarters · filed 2025-05-08 | $1.41M derived: sum of 3 quarters · filed 2025-05-08 | $689.00K derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $120.00K derived: sum of 2 quarters · filed 2025-03-06 | -$605.00K derived: sum of 3 quarters · filed 2025-03-06 | -$405.00K 10-K · filed 2025-03-06 | ||
| 2023-09-30 | -$492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.22M derived: sum of 2 quarters · filed 2024-11-07 | -$1.02M 10-Q · filed 2024-11-07 | -$1.09M 10-Q · filed 2023-11-13 | -$10.49M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$725.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$525.00K 10-Q · filed 2024-08-14 | -$586.00K 10-Q · filed 2023-08-14 | -$9.99M derived: sum of 3 quarters · filed 2024-08-14 | -$11.04M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $200.00K 10-Q · filed 2024-05-09 | -$9.27M derived: sum of 2 quarters · filed 2024-05-09 | -$10.31M derived: sum of 3 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$9.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$10.51M derived: sum of 2 quarters · filed 2024-03-01 | -$11.21M 10-K · filed 2024-03-01 | |||
| 2022-09-30 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$1.74M 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | -$697.00K 10-Q · filed 2023-08-14 | |||||
| 2021-12-31 | -$2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$3.44M derived: sum of 2 quarters · filed 2022-03-17 | -$1.93M derived: sum of 3 quarters · filed 2022-03-17 | -$7.71M 10-K · filed 2022-03-17 | ||
| 2021-09-30 | -$996.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $521.00K derived: sum of 2 quarters · filed 2021-11-10 | -$5.26M 10-Q · filed 2021-11-10 | $493.00K derived: sum of 4 quarters · filed 2022-03-17 | ||
| 2021-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$4.27M 10-Q · filed 2021-08-12 | $1.49M derived: sum of 3 quarters · filed 2022-03-17 | $3.06M derived: sum of 4 quarters · filed 2022-03-17 | ||
| 2021-03-31 | -$5.78M 10-Q · filed 2021-05-06 | -$28.00K derived: sum of 2 quarters · filed 2022-03-17 | $1.55M derived: sum of 3 quarters · filed 2022-03-17 | $2.06M derived: sum of 4 quarters · filed 2022-03-17 | ||
| 2020-12-31 | $5.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $7.33M derived: sum of 2 quarters · filed 2022-03-17 | $7.84M derived: sum of 3 quarters · filed 2022-03-17 | $17.14M 10-K · filed 2022-03-17 | ||
| 2020-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.09M derived: sum of 2 quarters · filed 2021-11-10 | $11.38M 10-Q · filed 2021-11-10 | $12.10M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $9.81M 10-Q · filed 2021-08-12 | $10.52M derived: sum of 3 quarters · filed 2021-08-12 | $9.68M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $9.30M 10-Q · filed 2021-05-06 | $10.01M derived: sum of 2 quarters · filed 2021-05-06 | $9.17M derived: sum of 3 quarters · filed 2021-05-06 | $8.62M derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $713.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$127.00K derived: sum of 2 quarters · filed 2021-03-04 | -$673.00K derived: sum of 3 quarters · filed 2021-03-04 | -$373.00K 10-K · filed 2021-03-04 | ||
| 2019-09-30 | -$840.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$1.39M derived: sum of 2 quarters · filed 2020-11-05 | -$1.09M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$546.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$246.00K 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | $300.00K 10-Q · filed 2020-05-11 | |||||
| 2018-12-31 | $308.00K 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |